A citation-based method for searching scientific literature

Ramandeep Kaur, Lalita Dahiya, Manoj Kumar. Eur J Med Chem 2017
Times Cited: 24







List of co-cited articles
91 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Jianbo Bie, Shuainan Liu, Zhanmei Li, Yongzhao Mu, Bailing Xu, Zhufang Shen. Eur J Med Chem 2015
14
50

MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
Mark D Erion, Paul D van Poelje, Qun Dang, Srinivas Rao Kasibhatla, Scott C Potter, M Rami Reddy, K Raja Reddy, Tao Jiang, William N Lipscomb. Proc Natl Acad Sci U S A 2005
83
29

Current anti-diabetic agents and their molecular targets: A review.
Nagaraju Kerru, Ashona Singh-Pillay, Paul Awolade, Parvesh Singh. Eur J Med Chem 2018
67
29

Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
Mark D Erion, Qun Dang, M Rami Reddy, Srinivas Rao Kasibhatla, Jingwei Huang, William N Lipscomb, Paul D van Poelje. J Am Chem Soc 2007
48
25

Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.
Qun Dang, Brian S Brown, Yan Liu, Robert M Rydzewski, Edward D Robinson, Paul D van Poelje, M Rami Reddy, Mark D Erion. J Med Chem 2009
24
25

T-to-R switch of muscle fructose-1,6-bisphosphatase involves fundamental changes of secondary and quaternary structure.
Jakub Barciszewski, Janusz Wisniewski, Robert Kolodziejczyk, Mariusz Jaskolski, Dariusz Rakus, Andrzej Dzugaj. Acta Crystallogr D Struct Biol 2016
15
33

Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
Ben-Ren Liao, Hai-Bing He, Ling-Ling Yang, Li-Xin Gao, Liang Chang, Jie Tang, Jing-Ya Li, Jia Li, Fan Yang. Eur J Med Chem 2014
11
45

Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
Qun Dang, Srinivas Rao Kasibhatla, Wei Xiao, Yan Liu, Jay Dare, Frank Taplin, K Raja Reddy, Gerard R Scarlato, Tony Gibson, Paul D van Poelje,[...]. J Med Chem 2010
27
20

Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.
Eric Kitas, Peter Mohr, Bernd Kuhn, Paul Hebeisen, Hans Peter Wessel, Wolfgang Haap, Armin Ruf, Jörg Benz, Catherine Joseph, Walter Huber,[...]. Bioorg Med Chem Lett 2010
18
27

Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
Paul D van Poelje, Scott C Potter, Visvanathan C Chandramouli, Bernard R Landau, Qun Dang, Mark D Erion. Diabetes 2006
51
20

3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.
Stephen W Wright, Anthony A Carlo, Dennis E Danley, David L Hageman, George A Karam, Mahmoud N Mansour, Lester D McClure, Jayvardhan Pandit, Gayle K Schulte, Judith L Treadway,[...]. Bioorg Med Chem Lett 2003
28
20

Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
Qun Dang, Srinivas Rao Kasibhatla, K Raja Reddy, Tao Jiang, M Rami Reddy, Scott C Potter, James M Fujitaki, Paul D van Poelje, Jingwei Huang, William N Lipscomb,[...]. J Am Chem Soc 2007
51
20

New insight into the binding modes of TNP-AMP to human liver fructose-1,6-bisphosphatase.
Xinya Han, Yunyuan Huang, Rui Zhang, San Xiao, Shuaihuan Zhu, Nian Qin, Zongqin Hong, Lin Wei, Jiangtao Feng, Yanliang Ren,[...]. Spectrochim Acta A Mol Biomol Spectrosc 2016
7
71

Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.
Qun Dang, Yan Liu, Daniel K Cashion, Srinivas Rao Kasibhatla, Tao Jiang, Frank Taplin, Jason D Jacintho, Haiqing Li, Zhili Sun, Yi Fan,[...]. J Med Chem 2011
59
16


Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.
Chunqiu Lai, Rebecca J Gum, Melissa Daly, Elizabeth H Fry, Charles Hutchins, Celerino Abad-Zapatero, Thomas W von Geldern. Bioorg Med Chem Lett 2006
30
16


Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.
Thomas W von Geldern, Chunqiu Lai, Rebecca J Gum, Melissa Daly, Chaohong Sun, Elizabeth H Fry, Celerino Abad-Zapatero. Bioorg Med Chem Lett 2006
28
16

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase.
Roger W Hunter, Curtis C Hughey, Louise Lantier, Elias I Sundelin, Mark Peggie, Elton Zeqiraj, Frank Sicheri, Niels Jessen, David H Wasserman, Kei Sakamoto. Nat Med 2018
66
16

Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites.
Paul Hebeisen, Bernd Kuhn, Philipp Kohler, Marcel Gubler, Walter Huber, Eric Kitas, Brigitte Schott, Jörg Benz, Catherine Joseph, Armin Ruf. Bioorg Med Chem Lett 2008
26
12

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.
I Magnusson, D L Rothman, L D Katz, R G Shulman, G I Shulman. J Clin Invest 1992
432
12

Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.
Qun Dang, Srinivas Rao Kasibhatla, Tao Jiang, Kevin Fan, Yan Liu, Frank Taplin, William Schulz, Daniel K Cashion, K Raja Reddy, Paul D van Poelje,[...]. J Med Chem 2008
25
12

Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.
Tomoharu Tsukada, Mizuki Takahashi, Toshiyasu Takemoto, Osamu Kanno, Takahiro Yamane, Sayako Kawamura, Takahide Nishi. Bioorg Med Chem Lett 2010
15
20

A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase.
Sabrina Heng, Kimberly R Gryncel, Evan R Kantrowitz. Bioorg Med Chem 2009
39
12

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
Amy K Rines, Kfir Sharabi, Clint D J Tavares, Pere Puigserver. Nat Rev Drug Discov 2016
112
12

Fructose-1,6-bisphosphatase opposes renal carcinoma progression.
Bo Li, Bo Qiu, David S M Lee, Zandra E Walton, Joshua D Ochocki, Lijoy K Mathew, Anthony Mancuso, Terence P F Gade, Brian Keith, Itzhak Nissim,[...]. Nature 2014
254
12


Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection.
Xiao-Xue Zhu, Da-Long Zhu, Xiao-Ying Li, Ya-Lin Li, Xiao-Wei Jin, Tian-Xin Hu, Yu Zhao, Yong-Guo Li, Gui-Yu Zhao, Shuang Ren,[...]. Diabetes Obes Metab 2018
10
30

Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.
André J Scheen, Nicolas Paquot, Pierre J Lefèbvre. Expert Opin Investig Drugs 2017
31
12

Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase.
Qu Fan Collins, Hui-Yu Liu, Jingbo Pi, Zhenqi Liu, Michael J Quon, Wenhong Cao. J Biol Chem 2007
197
8

CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Taishi Yoshida, Akira Okuno, Masanori Izumi, Kanako Takahashi, Yuka Hagisawa, Jun Ohsumi, Toshihiko Fujiwara. Eur J Pharmacol 2008
11
18

Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines.
S W Wright, D L Hageman, L D McClure, A A Carlo, J L Treadway, A M Mathiowetz, J M Withka, P H Bauer. Bioorg Med Chem Lett 2001
19
10

Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectors.
Jun-Young Choe, Scott W Nelson, Kristen L Arienti, Frank U Axe, Tassie L Collins, Todd K Jones, Rachel D A Kimmich, Michael J Newman, Karl Norvell, William C Ripka,[...]. J Biol Chem 2003
29
8


Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography.
Stephen W Wright, Anthony A Carlo, Maynard D Carty, Dennis E Danley, David L Hageman, George A Karam, Carolyn B Levy, Mahmoud N Mansour, Alan M Mathiowetz, Lester D McClure,[...]. J Med Chem 2002
51
8

Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate.
S J Pilkis, M R El-Maghrabi, J Pilkis, T Claus. J Biol Chem 1981
156
8

Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors.
Michela Rosini, Francesca Mancini, Andrea Tarozzi, Francesco Colizzi, Vincenza Andrisano, Maria L Bolognesi, Patrizia Hrelia, Carlo Melchiorre. Bioorg Med Chem 2006
5
40

Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
Paul Hebeisen, Wolfgang Haap, Bernd Kuhn, Peter Mohr, Hans Peter Wessel, Ulrich Zutter, Stephan Kirchner, Armin Ruf, Jörg Benz, Catherine Joseph,[...]. Bioorg Med Chem Lett 2011
9
22

Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.
D L Rothman, I Magnusson, L D Katz, R G Shulman, G I Shulman. Science 1991
324
8

The allosteric site of human liver fructose-1,6-bisphosphatase. Analysis of six AMP site mutants based on the crystal structure.
M Gidh-Jain, Y Zhang, P D van Poelje, J Y Liang, S Huang, J Kim, J T Elliott, M D Erion, S J Pilkis, M Raafat el-Maghrabi. J Biol Chem 1994
44
8

Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hidenari Hirata, Keishi Sugimachi, Hisateru Komatsu, Masami Ueda, Takaaki Masuda, Ryutaro Uchi, Shotaro Sakimura, Sho Nambara, Tomoko Saito, Yoshiaki Shinden,[...]. Cancer Res 2016
61
8

Rational design, synthesis, and potency of N-substituted indoles, pyrroles, and triarylpyrazoles as potential fructose 1,6-bisphosphatase inhibitors.
Aleksandra Rudnitskaya, Dmitry A Borkin, Ken Huynh, Béla Török, Kimberly Stieglitz. ChemMedChem 2010
12
16


In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors.
Yunyuan Huang, Bo Chi, Yanhong Xu, Rongrong Song, Lin Wei, Li Rao, Lingling Feng, Yanliang Ren, Jian Wan. J Mol Graph Model 2019
2
100

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
237
8

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. Diabetes Res Clin Pract 2017
8

Sulforhodamine B colorimetric assay for cytotoxicity screening.
Vanicha Vichai, Kanyawim Kirtikara. Nat Protoc 2006
8

Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery.
Kenneth K Hallenbeck, David M Turner, Adam R Renslo, Michelle R Arkin. Curr Top Med Chem 2017
26
8

Covalent inhibitors design and discovery.
Stephane De Cesco, Jerry Kurian, Caroline Dufresne, Anthony K Mittermaier, Nicolas Moitessier. Eur J Med Chem 2017
92
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.